跳至主要内容
临床试验/NCT01645371
NCT01645371已完成不适用

Assessing the Content Validity of a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation

AstraZeneca0 个研究点目标入组 79 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
79
主要终点
Semi-structured discussion guide

研究概览

简要总结

This qualitative research is to assess the validity of the stool symptom screener that will be used in patients with chronic opioid-induced constipation to determine the adequacy of their response to laxatives.

详细描述

Assessing the Content Validity of a Stool Symptom Screener in Patients with Chronic Opioid-Induced Constipation

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 84 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Receiving a stable maintenance opioid regimen (total daily dose of 30-1000mg of oral morphine, or equianalgesic amounts of 1 or more other opioid therapies) for a minimum of 4 weeks for non-cancer related pain.
  • Development of constipation symptoms since starting opioids.
  • Taken laxatives to help with bowel movements for at least four days over the past 2 weeks.

排除标准

  • Receiving opioid regimen for treatment of pain related to cancer.
  • Participated in any clinical trial or research study relating to opioid use and/or constipation within the past year.
  • History of cancer within 5 years from the time of screening.
  • Has medical condition(s) and/or treatment(s) associated with diarrhea, intermittent loose stools, or constipation (e.g., fecal incontinence or chronic idiopathic constipation).
  • Has irritable bowel syndrome (IBS) or chronic functional constipation.

结局指标

主要结局

Semi-structured discussion guide

时间窗: Data will be collected at ONE time point from each patient using a semi-structured interview guide (up to 5 months)

Using a semi-structured discussion guide during a single one-on-one interview, qualitative information will be collected from subjects that relates to their experience with Opioid Induced Constipation symptoms and to their understanding and perception of a verbally-administered stool symptom screener.

次要结局

未报告次要终点

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

相似试验

Assessing a Stool Symptom Screener in Patients With... | 临床试验